Vomiting
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Over 18 years old; have a diagnosis of cervical cancer with histological confirmation; have an indication for treatment with cisplatin 40mg/m² weekly associated with radiotherapy; preserved capsule swallowing capacity
Exclusion criteria
Exclusion criteria: Have a history of hypersensitivity to ginger; pregnancy or breastfeeding; have another primary neoplasm; ongoing chemotherapy treatment; having undergone previous antineoplastic and/or radiotherapy treatment; radiotherapy treatment in the epigastric region of the abdomen; surgery scheduled during the study period; have any feeding device (nasoenteric tube, gastrostomy, or jejunostomy); in simultaneous use of a supplement or ginger-based foods; using anticoagulants; have a history of bleeding disorders (severe thrombocytopenia), hyperthyroidism, and heart disease; a pre-existing condition causing nausea and vomiting.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess the reduction of nausea and vomiting using the Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 scale adapted for nausea and vomiting. In this way, it is possible to measure the intensity and intensity of events. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the quality of life of patients using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ C30) and EORTC quality of life cervical cancer module (EORTC QLQ Cx24). With these instruments it is expected to analyze the interference of the treatment in the quality of life, as well as the influence of ginger in its improvement. | — |
Countries
Brazil